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Abstract
Objective: To assess the sensitivity to change of the McMaster Toronto Arthritis Patient Preference Disability Questionnaire
(MACTAR) in chronic low back pain (CLBP) and shifts in patients’ priorities of disabling activities over time.
Methods: A prospective longitudinal survey of 100 patients (38 males) with CLBP in a tertiary care teaching hospital.
Evaluation at baseline and 6 months by the MACTAR, Quebec Back Pain Disability Questionnaire (QUEBEC), Hospital Anxiety
and Depression scale (HAD), Fear-Avoidance Beliefs Questionnaire (FABQ), Coping Strategies Questionnaire (CSQ), and pain
and handicap visual analogue scales (VASs). Patients’ perceived improvement or worsening of condition was assessed at 6
months. Effect size (ES) and Standardized response mean (SRM) and effect size (ES) were used to evaluate sensitivity to
change of the MACTAR.
Results: The MACTAR SRM and ES values (SRM=0.25; ES=0.37) were among the highest for the instruments evaluated. For
patients considering their condition as improved, the SRM was 0.66 and the ES 1. The 3 disability domains, classified by the
International Classification of Functioning, Disability and Health (ICF), most often cited as priorities at baseline remained the
most cited at follow-up: mobility (40.9% of patients); community, social and civic life (22.7%); and domestic life (22.4%). At 6
months, 48 patients shifted their priorities, for a decrease in MACTAR SRM and ES values for patients considering their
condition improved and an increase in these values for those considering their condition deteriorated.
Conclusions: Although the MACTAR has similar sensitivity to change as other outcome measures widely used in CLBP, shifts
in patient priorities over time are common and influence scores and sensitivity to change.
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Introduction
Non-specific low back pain (LBP) is a major health and
socioeconomic problem in the industrialized world [1–3]. Chronic
LBP (CLBP) occurs if the pain persists more than 12 weeks, and
recovery is slow and uncertain [4]. In addition, some of these cases
of CLBP (disabling CLBP) impose a huge burden on healthcare
systems, cause significant disability and absence from work, and
account for a substantial proportion of medical consultations
[1,2,4–7]. Therefore, outcome measures with good metric pro-
perties assessing disability and participation restriction are needed
to measure evolution and treatment efficacy in CLBP.
Disability and participation restriction, also called handicap, are
negative aspects of functioning [7], and are widely assessed in
CLBP. Many outcome measures have been validated in this
situation. The instruments most commonly used are The Roland
Disability Questionnaire (0–24) [8,9], the Oswestry Disability
Index (0–100) [10,11], the Quebec Back Pain Disability
Questionnaire (QUEBEC; 0–100) [12,13], the visual analogue
scale (VAS; 0–100) [14] and the numerical rating scale (0–10) [14]
for pain and for function [15].
However, such measures of disability do not take into account
patient priorities. Previous research found that patients with
rheumatoid arthritis (RA), healthy professionals, and healthy
controls do not agree on the importance of disabilities [16]. Taking
into account such priorities may lead to a better understanding of
what is important for patients and an increase in the validity and
responsiveness of scales assessing disability [17]. An example of a
functional scale that investigates patient priorities is the McMaster-
Toronto Arthritis Patient Preference Disability Questionnaire
(MACTAR) [18]. Its developers noted good responsiveness for
patients with RA in a controlled trial that revealed a clinically
important change, and the scale was found to have validity in a
multicenter randomised trial of RA [19]. With the MACTAR, an
interviewer determines the activities the patient considers the most
important that are not able to be performed because of health
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comprehensive than that of traditional fixed-item questionnaires
and may reveal issues that really matter to the patient. Two recent
studies evaluating patient priorities in disability in systemic
sclerosis and disabling CLBP suggested that the MACTAR adds
useful information about disability [20,21].
However, the sensitivity to change of the MACTAR should be
established before its consideration as an outcome measure in
future trials of LBP. Results of a previous study of RA patients
suggested that frequent shifts in patients’ priorities over time may
alter the validity of the MACTAR in follow-up study [19]. As well,
shifts in priorities of systemic sclerosis patients recorded with the
instrument were suggested to influence the sensitivity to change of
the instrument [22]. Therefore, we aimed to assess the sensitivity
to change of the MACTAR for CLBP patients and the frequency
in shifts of patient priorities over time for implications for the
usefulness of the MACTAR for CLBP follow-up.
Methods
Study design
Patients: 261 in-patients admitted to the Physical Medicine and
Rehabilitation Department at Cochin University Hospital in Paris
for management of CLBP were asked to participate in the survey
between June 2007 and February 2008. The inclusion criteria
were non-specific LBP and disease duration of at least 3 months.
The exclusion criteria were age less than 18 years, sciatica without
back pain, LBP with suspected or proven serious spinal pathology,
inability to understand French or complete a self-administered
written questionnaire and uncontrolled mental diseases.
Overall 150 patients were evaluated at baseline during hospital
stay. At 6 months, these 150 patients were asked by mail to give
their overall opinion of CLBP evolution since hospitalization and
to complete the same questionnaires used for assessment at
baseline.
Demographic and clinical variables
Variables recorded at baseline were age, sex, occupation,
duration of sickness, work-related back pain, sick leave, sick leave
duration, back surgery, retained diagnosis, as well as LBP
intensity, radiating or sciatica pain intensity, and handicap
intensity on a VAS. At the 6-month follow-up, we assessed LBP
intensity, radiating or sciatica pain intensity, and handicap
intensity on a VAS, and patients were asked whether they
considered their CLBP alleviated, identical to or worse than at
baseline evaluation.
Handicap assessment
Disability and participation restriction. Patients’ priori-
ties in disability were assessed by use of the French version of the
MACTAR as described by Tugwell et al.[18]. At baseline evalua-
tion, patients were first asked about activities affected by CLBP.
To assist the patient, the interviewer read a series of probing
questions. The MACTAR questions are open-ended and cover
broad areas of function such as domestic care, self-care, pro-
fessional activities, leisure activities, social interaction, and roles.
Patients were encouraged to add activities not already listed. Then
patients were asked to rank these activities in order of importance
by answering ‘‘Which of these activities would you most like to be
able to do?’’ In a pilot study of 25 French patients with systemic
sclerosis, RA or generalized osteoarthritis, more than half of the
patients had difficulty identifying and ranking more than 3 items.
Moreover in the original MACTAR report, differences between
analyses for 3-item and 5-item priority functions were minimal
[18]. Thus, we used a 3-item priority function and asked patients
to identify and rank 3 situations among activities of daily living
that caused them maximal trouble. In the original MACTAR,
items were not scored, but patients were asked if they had noticed
changes in the problem they had identified several weeks previous.
In the validation study of MACTAR, a Likert scale was added to
quantify changes [19]. In the present work, to reflect the degree of
difficulty in performing a priority activity, each item was scored on
an 11-point quantitative scale (0–10), the global score ranging
from 0 (no disability) to 30 (maximal disability), as was done in the
survey assessing patients’ disability priorities in systemic sclerosis
[20] and disabling CLBP [21]. This global score reflects the
burden induced by CLBP in performing activities of daily living
that matter most to the patient.
At follow-up evaluation, patients were reminded of the 3
baseline priority activities they identified and were asked to score
these activities on the same 11-point scale. To assess possible shifts
in patient priorities, participants were asked to define and score 1
to 3 other activities that may have become more important to
them since baseline. Patients who shifted priorities had two
MACTAR scores at 6 months. One score was calculated by
adding the scores for the 3 priorities in disability chosen at baseline
and re-scored at follow-up. The other follow-up global score was
calculated by adding the scores for the 3 priorities in disability
selected at follow-up. For example, if a patient chose activities 1, 2,
and 3 at baseline but decided at follow-up that a new activity
(named 4) had become more important than activity 3 chosen at
baseline, the MACTAR scores at follow-up were 1+2+3
(corresponding to MACTAR considering priorities defined at
baseline at 6-month evaluation) and 1+2+4 (corresponding to
MACTAR considering shifts in priorities at 6-month evaluation).
In both cases, changes in MACTAR global score were calculated
by subtracting the follow-up score from the baseline score.
To classify the different activities identified by patients, we used
the domains of the International Classification of Functioning,
Disability and Health (ICF) [23] with the 10 linking rules given by
the World Health Assembly in May 2001. According to these
rules, each item of an activity should be linked to the most precise
ICF category, and if concepts refer to more than one ICF
category, then all the ICF categories to which the concepts refer
should be linked [23,24]. So, one activity may correspond to 2
domains; for example, running belongs to the mobility domain (d
4552: running) and the community, social and civic life domain (d
9201: sports).
Disability was also assessed at baseline and at follow-up by use
of the Quebec back pain disability questionnaire (QUEBEC), with
20 items concerning daily activities, each question scored on a
scale from 0 (performed without difficulty) to 5 (impossible to do).
The total score is obtained by adding the scores of all items (range
0–100). This questionnaire has been validated in CLBP [12,13].
Global handicap assessment. A VAS was used to evaluate
patients’ global opinion of their handicap at baseline and follow-
up. The scale ranged from 0, handicap absent or normal capacity
for doing a daily life activity, to 100, impossible to do a daily life
activity or handicap to the highest degree.
Psychological status assessment. Outcome measures assess-
ing patients’ psychological status were recorded to ascertain whether
their changes over time were less well correlated with MACTAR
score changes than with changes in other physical handicap and
disability scale scores (divergent validity).
Coping strategies assessment. The CSQ
25 is a 48-item
self-reporting measure of cognitive and behavioural coping
strategies. Items are rated on a 7-point Likert scale. Recent
factor analyses of the CSQ items by principal components and
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represented by a 6-factor solution of praying, ignoring pain
sensations, distancing from pain, catastrophizing, coping self-
statements, and distractions. In the present study, with the 6-factor
solution and items ranked on a 4-point Likert scale, the score for
each factor was obtained by adding the scores of items belonging
to the factor: 8, 19, and 26 for praying; 12, 14, 22 and 25 for
ignoring pain sensations; 1, 10, 20 and 29 for distancing from pain;
3, 6, 15, 23 and 27 for catastrophizing; 4, 5, 7, 9, 11, 13, 17 and 21
for coping self-statements; and 2, 16, 18, 24, and 28 for
distractions. The internal consistency of the original subscales of
the CSQ was demonstrated for patients with chronic pain [25]
and university students [28]. The test–retest reliability of the items
and the original subscales of the CSQ have been shown to be
adequate over a period of 24 hours [29]. This questionnaire has
been validated in French [30].
Fear-avoidance beliefs assessment. The fear-avoidance
model proposes an explanation of why for some patients, back
pain eventually leads to chronic disability. Patients with a high
level of pain-related fears come to have a catastrophic inter-
pretation that activity will cause injury and exacerbate the pain
[31–33].
The FABQ [34] considers two subscales: the FABQ Phys
assesses attitudes and beliefs related to general physical activities (4
items: 2, 3, 4, 5, range 0–24) and the FABQ Work assesses
attitudes and beliefs related to occupational activities (7 items: 6, 7,
9,10, 11,12,15, range 0–42). Each item is scored from 0, do not
agree at all, to 6, completely agree. For both subscales, a low score
indicates low fear-avoidance beliefs, and a score of 14 or more on
the FABQ Phys indicates strong fear-avoidance beliefs [34,35].
This questionnaire has been validated in English [34], German
[36] and French [37].
Anxiety and depression assessment. Anxiety and
depression were assessed by use of the Hospital Anxiety and
Depression scale (HADa and HADd) [38]. This scale has 7
questions for anxiety and 7 for depression. Scores for each
question range from 1 to 3, and the total score ranges from 0 (no
depression, no anxiety) to 21 (maximal depression, maximal
anxiety).
Ethical considerations (Local institutional review board:
Comite ´ de protection des personnes Paris centre, groupe
hospitalier Cochin-Broca-Ho ˆtel Dieu)
This survey was conducted in compliance with the protocol
Good Clinical practices and Declaration of Helsinki principles. In
accordance with the French national law (loi Huriet), a formal
approval from an ethical committee is not required for this kind of
project; patients gave their written consent to participate after
being informed about the study protocol.
Statistical analysis
Data analysis involved Systat 9 (SPSS Inc., Chicago, USA).
Quantitative variables are described with means 6 standard
deviations (SD) and ranges. Qualitative variables are described
with proportions and percentages.
Responsiveness may be considered an aspect of validity [39]
and describes a scale’s ability to detect change over time that is
clinically meaningful [40]. Different statistical approaches are
used to assess sensitivity to change [40,41]. Standardized
response mean (SRM) is defined as the mean change in scores
between the baseline and follow-up visit divided by the SD of the
individual changes in scores. A high SRM indicates greater
responsiveness. A negative value indicates that the mean score at
the baseline visit is smaller than the mean score at the follow-up
visit. Effect size (ES) is defined as the mean change in scores
between baseline and the follow-up visit divided by the SD of the
baseline score. A high ES indicates greater responsiveness. A
negative value indicates that the mean score at the baseline visit
is smaller than the mean score at the follow-up visit. The ES and
SRM are considered small if ,0.2, moderate if near 0.5, and
large if .0.8. The minimal clinically detectable improvement
(MCDI) was calculated for the MACTAR as the 75
th percentile
of the change in MACTAR scores for those who reported
improvement. Spearman’s correlation coefficient (r) was used to
study the relation between the individual changes as assessed by
the MACTAR and scores for other assessment tools. Spearman’s
correlation was interpreted as excellent (.0.91), good (0.90–
0.71), moderate (0.70–0.51), fair (0.50–0.31), and little or absent
(,0.30) [42].
With a responsive outcome measure, scores improve when the
patient’s condition improves, are identical when the condition
does not change, and are worse when the condition deteriorates
[43]. SRM values were also calculated for the subgroups of
patients who considered their condition improved (patient’s overall
opinion of their condition at 6-month follow-up as improved or
slightly improved), maintained the same health status (patient’s
overall opinion of their condition at follow-up as identical) and
considered their condition deteriorated (patient’s overall opinion
of their condition at follow-up as being worse or slightly worse).
Then these 3 groups of scores were recoded into 2 groups of
scores, considering actual health status improved (patient’s overall
opinion at follow-up as improved or slightly improved) or
deteriorated (patient’s overall opinion at follow-up as identical,
worse, or slightly worse). The nonparametric Mann-Whitney U
test was used to compare changes in scores in these 2 last groups of
scores. Stepwise logistic regression analysis was used to determine
the variables associated with patients’ opinion of their actual status
of health. Explanatory variables were introduced in the stepwise
regression process if on univariate analysis significant differences in
scores were found between patients who considered their health
condition improved and those deteriorated. Maximum likelihood
method of estimation was used.
For all tests, a P,0.05 was considered statistically significant.
Results
Demographic and clinical data
Overall, data for 150 patients could be evaluated at baseline.
Mean age at the time of evaluation was 54.3615.8 years and
mean disease duration 93692.4 months. Forty-six patients
(30.7%) were receiving compensation claims, 68 (45.3%) were
on sick leave, and 28 (18.7%) had work-related back pain [21].
In total, 100 patients (62 female) underwent a second evaluation
during a follow-up visit at 6.0562.29 months [range 3–11].
Among the 50 patients lost to follow-up, 1 was hospitalized for a
stroke, 2 declined to participate, 5 returned incomplete surveys,
and 42 could not be reached. These patients were less likely to be
female (54%) than those included in the analysis but did not differ
for other parameters (14 [28.0%] were receiving compensation
claims, 25 [50.0%] were on sick leave, and 10 [20.0%] had work-
related back pain). Demographic and clinical parameters of the
100 patients are in Table 1.
Priority disabilities
Priority disabilities were individual and differed for each
participant. At follow-up, 52 patients maintained the same
priorities as at baseline. For 48 patients, at least 1 of the 3
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changed. At baseline, the 100 patients cited 40 activities, which
corresponded to 6 ICF domains
23. Among the 40 activities, 17
were cited fewer than 5 times, and 7 only once. Considering the 3
main activities selected at baseline, the domains cited were
mobility (19 activities, cited 136 times, 37.7% of patients);
community, social and civic life (7 activities, cited 89 times,
24.7% of patients); domestic life (7 activities, cited 85 times, 23.5%
of patients); major life areas (1 activity, cited 26 times, 7.6% of
patients); interpersonal interactions and relationships (3 activities,
cited 13 times, 3.6% of patients); and self-care (3 activities, cited 12
times, 3.3% of patients). Among the domains chosen as the first
priority disability, the 3 identified most often were mobility (14
activities, cited 41 times, 34.7% of patients); community, social
and civic life (5 activities, cited 32 times, 27.1% of patients); and
domestic life (6 activities, cited 29 times, 24.6% of patients).
The 10 activities most often cited were sports (n=38, 38% of
patients), walking (n=34, 34%), recreation and leisure (n=32,
32%), shopping (n=28, 28%), cleaning (n=27, 27%), work and
employment (n=26, 26%), moving around outside the home and
other buildings (n=25, 25%), driving (n=17, 17%), mobility
unspecified (n=14, 14%) and taking care of plants (n=12, 12%).
Twenty-eight different activities were ranked number one, and of
these, the 3 most often identified by patients as the first priority
were sport (n=16 times, 16% of patients), work (n=12, 12%) and
cleaning living areas (n=10, 10%) (appendix Table S1).
Shift in priorities at 6-month evaluation did not modify the
order of domains when considering the 3 priorities or the first
priority cited. For the 3-priority analysis, the domains were
mobility (40.9% of patients); community, social and civic life
(22.7%); domestic life (22.4%); major life areas (7.7%); interper-
sonal interactions and relationships (3.2%); and self-care (3.2%).
For the first-priority analysis, the order of domains was the same.
When looking at activities, their frequency of citation in each
domain changed at 6 months. Considering the 3 priorities or the
first priority at 6 months, the two groups were identical in the 3
Table 1. Demographic and clinical characteristics for 100 patients with chronic low back pain at baseline visit and 50 patients lost
to follow-up at 6 months.
100 patients 50 patients
Age at the time of evaluation (mean 6SD) [range] 54.2615.2 [20–85] 54.8617.5 [24–86]
Sex (female, %) 62 (62.0) 27 (54)
Claim compensation (yes, %) 33 (33.0) 14 (28)
Sick leave (yes, %) 39 (39.0) 25 (50)
Work-related low back pain (yes, %) 18 (18.0) 10 (20)
Sick leave duration (months, mean 6SD) [range] 24.6630.0 [0.25–120] 15.2628.8 [0–127]
Disease duration at the time of evaluation (months, mean6SD) [range] 89.6685.0 [3–408] 102.46105.6 [4–612]
BMI (mean 6SD) [range] 27.265.4[18.4–45.7] 26.765.3[16.7–39.9]
Predominant low back pain (yes, %) 70 (70.0) 31 (62.0)
Predominant sciatica (yes, %) 16 (16.0) 11 (22.0)
Equal intensity of low back and sciatica pain (yes, %) 14 (14.0) 8 (16.0)
Radicular pain topography, S1 (yes, %) 6 (20.0) 6 (31.6)
Radicular pain topography, L5 (yes, %) 13 (43.3) 6 (31.6)
Radicular pain topography, L4 (yes, %) 2 (6.7) 1 (5.3)
Radicular pain topography, L3 (yes, %) 1 (3.3) 1 (5.3)
Radicular pain topography, undetermined (yes, %) 6 (20.0) 3 (15.7)
Radicular pain topography, multiple (yes, %) 2 (6.7) 2 (10.5)
Lumbar discopathy (yes, %) 37 (37.0) 19 (38.0)
Spondylolisthesis (yes, %) 14 (14.0) 5 (10.0)
Facet joint osteoarthritis (yes,%) 42 (42.0) 19 (38.0)
Lumbar spine stenosis (yes, %) 28 (28.0) 11 (22.0)
Disk herniation (yes, %) 25 (25.0) 14 (28.0)
No anatomic diagnosis (yes, %) 13 (13.0) 28 (56.0)
Previous back surgery (yes, %) 28 (28.0) 11 (22.0)
Lumbar support (yes, %) 34 (34.0) 18 (36.0)
Physical therapy (yes, %) 96 (96.0) 47 (94.0)
Spinal infiltration (yes, %) 67 (67.0) 35 (70.0)
Anti-depressant perfusions (yes, %) 71 (71.0) 32 (64.0)
Social and psychological support (yes, %) 56 (56.0) 27 (54.0)
Hospital stay duration (days, mean 6SD) [range] 8.962.4 [2–12] 8.462.8[2–14]
BMI: Body mass index.
SD: Standard Deviation.
doi:10.1371/journal.pone.0020274.t001
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Table S1).
For the 48 patients who shifted at least one priority (appendix
Table S2), the order of domains remained the same, but activities
changed.
Outcome measure scores
The mean MACTAR total score and score for other outcome
measures for the 100 patients at baseline and follow-up are in
Table 2.
The mean MACTAR score at 6-month evaluation when
considering the same priorities defined at baseline was 17.967.6
[2.2–30], whereas the mean MACTAR score at 6-month
evaluation when considering shifts in priorities was 19.667.5
[2.2–30]. For the 48 patients who shifted at least one priority, the
mean MACTAR score at baseline was 20.365.5 [7.8–30] and
18.766.4 [4–29.4] at 6-month follow-up when considering the
priorities defined at baseline and 22.265.3 [8–30] when
considering shifted priorities.
Comparison between patients maintaining baseline
priorities and those shifting priorities
As indicated in Table 3, patients who shifted priorities and those
who maintained their baseline choice showed no differences in
baseline characteristics, changes between baseline and follow-up,
or ratio of considering their condition as improved or deteriorated,
except for changes in scores for the MACTAR with a shift in
priorities and in FABQ Work.
Sensitivity to change
The sensitivity to change of the measures evaluated by the SRM
and ES is in Table 2. For patients who did not change priorities,
the MACTAR values for SRM (0.25) and ES (0.37) were among
the highest for the measures compared. The MACTAR SRM and
ES values were slightly higher than those for the 2 other disability
scales (QUEBEC, 0.23 and 0.20; VAS handicap, 0.22 and 0.32,
respectively). The other measures with high responsiveness were
LBP on a VAS (SRM and ES, 0.33 and 0.63, respectively) and
sciatica pain on a VAS (SRM and ES, 0.29 and 0.37, respectively).
Individual changes in the MACTAR score (appendix Table S3)
showed a moderate correlation with the QUEBEC and global
handicap VAS scores (r=0.61 and 0.53, respectively) and a
fair correlation with changes in sciatica pain on a VAS, LBP on a
VAS and FABQ Phys scores (r=0.43, r=0.39 and r=0.39,
respectively).
Table 4 summarizes individual MACTAR changes in scores for
the patients who considered their condition improved (46 patients),
unchanged (18 patients) and deteriorated (36 patients) at 6 months.
The MACTAR scale, whether baseline priorities were retained or
had shifted, discriminates well between patients who considered
their condition improved and those deteriorated (SRM=0.66 and
20.21, respectively, Mann-Whitney test P=0.0001, between
means of individual changes in the 2 groups for the MACTAR
with same priorities defined at baseline; and SRM=0.38 and
20.46, respectively, Mann-Whitney test P=0.001, between
means of individual changes in the 2 groups for the MACTAR
with shifts in priorities). The MCID value for the MACTAR score
Table 2. Scores for pain, disability, handicap, fear-avoidance beliefs, coping strategies and anxiety and depression for 100 patients
with chronic low back pain at baseline and at 6-month follow-up, differences in scores and sensitivity to change.
Baseline evaluation 6-month evaluation Difference
Mean S.D. Min Max Mean S.D. Min Max Mean S.D. Min Max ES/SRM
VAS low back pain intensity 66.0 15.4 30 100 56.4 26.7 0 100 9.7 30.5 243 87 0.63/0.33
VAS sciatica pain intensity 38.7 31.3 0 100 50.4 31.4 0 100 211.7 41 2100 75 0.37/0.29
VAS handicap 61.6 18.3 6 100 55.8 25 0 98 5.8 26 248 93 0.32/0.22
MACTAR* 19.9 5.5 6.3 30 17.9 7.6 2.2 30 2.0 7.9 218.6 22 0.37/0.25
MACTAR** 19.9 5.5 6.3 30 19.6 7.5 2.2 30 0.3 7.9 218.6 22 0.06/0.04
Quebec 52.4 15.9 7 87 49.1 19.8 10 92 3.3 14.3 247 44 0.20/0.23
Anxiety (HADa) 9.7 3.8 2 18 9.3 4.2 1 18 0.4 3.2 28 8 0.10/0.12
Depression (HADd) 7.9 3.7 1 17 7.8 4.3 0 20 0.1 3.7 210 9 0.02/0.02
Fear-avoidance beliefs (work) 22.2 12.9 0 42 22.4 12.9 0 42 20.2 11.3 226 34 0.01/0.01
Fear-avoidance beliefs (physical) 14.7 6.6 0 24 13.4 7.1 0 24 1.3 7.5 224 24 0.20/0.18
Coping strategies: distraction 13.4 3.8 5 20 13 3.9 5 20 0.4 4.1 29 14 0.10/0.09
Coping strategies: catastrophizing 13.8 3.8 7 20 13.9 4.2 5 20 0.4 4.1 29 14 0.02/0.02
Coping strategies: coping self-
statements
7.5 3.5 4 16 7.5 3.5 3 16 0.1 3.9 211 12 0.02/0.01
Coping strategies: ignoring pain 9.7 2.9 4 16 9.2 2.9 4 16 0.5 3.3 212 7 0.19/0.16
Coping strategies: praying 6.5 3.4 2 12 6.4 3.6 3 12 0.1 3.9 211 12 0.02/0.01
Coping strategies: distancing from
pain
24 4.3 11 32 23.2 5.1 8 32 0.9 5 214 13 0.20/0.17
VAS: Visual Analogue Scale; MACTAR: McMaster-Toronto Arthritis Patient Preference Disability Questionnaire; Quebec: The Quebec Back Pain Questionnaire; HADa:
Hospital Anxiety and Depression Scale for anxiety; HADd: Hospital Anxiety and Depression Scale for depression; FABQ work: Fear-Avoidance Beliefs Questionnaire for
professional activities; FABQ phys: Fear-Avoidance Beliefs Questionnaire for physical activities; CSQ: Coping Strategies Questionnaire, ES: effect size; SRM: standardized
response mean
*considering priorities defined at baseline at 6-month evaluation;
**considering shifts in priorities at 6-month evaluation.
doi:10.1371/journal.pone.0020274.t002
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health by MACTAR score taking into account or not shifting priorities in activities of disability.
Patients with shift n=48 Patients without shift n=52
Mean S.D. Min Max Mean S.D. Min Max
BASELINE values
Age at the time of evaluation 54.1 13.6 26 85 54.4 16.6 20 82
Sex (female, %) 28 (58.3) 34 (65.4)
Claim compensation (yes, %) 15 (31.3) 18 (34.6)
Sick leave (yes, %) 21 (43.8) 18 (34.6)
Work-related low back pain (yes, %) 12 (25.0) 6 (11.5)
Sick leave duration 9.8 21.6 0 120 12.03 28.1 0 128
Disease duration at the time of evaluation 90.1 80.3 3 336 89.2 89.9 3 408
VAS low back pain intensity at baseline (0–100) 66.9 15.6 30 100 65.2 15.3 30 95
VAS sciatica pain intensity at baseline (0–100) 44.1 32.9 0 100 33.6 29.2 0 92
VAS handicap (0–100) 61.9 17.0 20 100 61.3 19.6 6 100
MACTAR (0–30) 20.3 5.5 7.8 30 19.6 5.5 6.3 27.3
Quebec (range 0–100) 55.0 15.9 7 87 49.9 15.7 20 86
Anxiety (HADa) (range 0–21) 9.3 3.8 2 16 10 3.8 2 18
Depression (HADd) (Range 0–21) 7.5 3.8 1 17 8.2 3.6 2 16
Fear-avoidance beliefs for Work activities (range 0–42) 22.6 13.0 0 42 21.9 13.0 0 42
Fear-avoidance beliefs for Physical activities(range 0–24) 14.6 6.4 0 24 14.8 6.9 0 24
Coping strategies: Distraction (range 0–20) 13.0 3.8 5 20 13.7 3.8 5 20
Coping strategies: Catastrophizing (range 0–20) 14.4 3.8 7 20 13.3 3.7 7 20
Coping strategies: Coping Self Statements (range0–16) 7.9 3.5 4 16 7.2 3.4 4 16
Coping strategies: Ignoring Pain Sensations (range0–16) 9.6 3.0 4 16 9.8 2.8 4 16
Coping strategies: Praying (range 0–12) 6.6 3.3 2 12 6.3 3.6 3 12
Coping strategies: Distancing from Pain (range 0–32) 23.8 3.7 14 32 24.2 4.8 11 31
DIFFERENCES: baseline vs. 6 month evaluation
VAS low back pain intensity at baseline (0–100) 10.6 27.4 238 80 8.8 33.3 -43 87
VAS sciatica pain intensity at baseline (0–100) 212.6 35.3 282 60 210.9 45.9 2100 75
VAS handicap (0–100) 3.0 24.4 248 60 8.3 27.5 240 93
MACTAR (0–30) * 1.6 7.1 212.2 15.7 2.4 8.6 218.6 22
MACTAR (0–30) ** 21.9 6.3 216.2 13.4 NA NA NA NA
Quebec (range 0–100) 2.9 14.3 247 33 3.6 14.5 221 44
Anxiety (HADa) (range 0–21) 20.04 3.7 2880 . 82 . 5 237
Depression (HADd) (Range 0–21) 20.31 3.5 210 7 0.5 3.8 299
Fear-avoidance beliefs for Work activities (range 0–42) 22.5 9.7 226 25 2 12.4 218 34
Fear-avoidance beliefs for Physical activities(range 0-24) 0.8 6.8 215 16 1.8 8.1 224 24
Coping strategies: Distraction (range 0–20) 20.06 4.3 28 14 0.8 3.9 291 1
Coping strategies: Catastrophizing (range –20) 20.06 4.3 28 14 0.8 3.9 291 1
Coping strategies: Coping Self Statements (range 0–16) 0.3 3.9 271 2 20.2 3.9 211 8
Coping strategies: Ignoring Pain Sensations (range 0–16) 0.2 2.9 2570 . 83 . 7 212 7
Coping strategies: Praying (range 0–12) 0.3 3.9 271 2 20.2 3.9 211 8
Coping strategies: Distancing from Pain (range 0–32) 1.2 4.5 27 13 0.6 5.5 214 13
ACTUAL STATUS OF HEALTH
Improved (yes, %) 23 (47.9) 23 (44.2)
Deteriorated (yes, %) 25 (52.1) 29 (55.8)
VAS: Visual Analogue Scale; MACTAR: McMaster-Toronto Arthritis Patient Preference Disability Questionnaire; QUEBEC: The Quebec Back Pain Questionnaire; HADa:
Hospital Anxiety and Depression Scale for anxiety; HADd: Hospital Anxiety and Depression Scale for depression; FABQ work: Fear-Avoidance Beliefs Questionnaire for
professional activities; FABQ phys: Fear-Avoidance Beliefs Questionnaire for physical activities; CSQ: Coping Strategies Questionnaire. NA: Not applicable
*considering priorities defined at baseline at 6-month evaluation;
**considering shifts in priorities at 6-month evaluation.
doi:10.1371/journal.pone.0020274.t003
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defined at baseline were retained and 8.4 with shifts in priorities.
Predictors of improved health status at 6 months
On univariate analysis, scores for patients who considered their
health status improved and those deteriorated at 6-month follow-
up significantly differed in changes in LBP on a VAS, sciatica pain
on a VAS, global handicap on a VAS, MACTAR score (same
priorities as at baseline or shift in priorities), the QUEBEC, the
HAD for depression, and the FABQ Phys. On stepwise logistic
regression, 2 variables were associated with patients’ opinion of
their health status at follow-up: changes in LBP on a VAS (odds
ratio [OR] 1.063, 95% confidence interval [CI] 1.036–1.091) and
changes in MACTAR score considering shifts in priorities (OR
1.083, 95% CI 1.002–1.171).
Discussion
This study strongly suggests that the MACTAR scale is as
responsive to change as other outcome measures widely used for
CLBP. However, we confirm that patients often shift priorities in
disabling activities during this condition, and we provide for the
first time implications of this shift on sensitivity to change of this
questionnaire.
For patients who retained the same 3 priorities selected at
baseline at 6-month follow-up, the SRM and ES values for the
MACTAR were similar to those for the QUEBEC back-pain
disability questionnaire, for which good sensitivity to change had
previously been reported [44,45], which suggests that the
MACTAR is a responsive outcome measure. Moreover, the
MACTAR score, considering or not changes in priorities,
increased in patients who felt better, did not change for patients
who felt their health unchanged, and was worse for patients who
felt worse, which characterizes a clinically meaningful sensitivity to
change. The scale differentiates well patients who felt improved
from those who felt their health unchanged or worse, which
characterizes a statistically significant sensitivity to change.
Almost half of the CLPB patients shifted their priorities from
those defined at baseline, which has several implications. Although
the domains of disability according to the ICF were not modified,
when considering the 3 priorities or the first priority cited at 6-
month evaluation, the specific activities and their frequencies in
each domain were changed. Therefore, despite having a chronic
pain condition, patients often show changed expectations over time,
and one advantage of using the MACTAR is that it probably
captures well what is most important to the patient at one moment
in time. This feature could help in developingindividualtherapeutic
strategies. One study of RA patients found that two-thirds of
prioritized impaired activities were new at 1-year follow-up [19].
Shifts in priorities also had an impact on the MACTAR global
score, sensitivity to change, and MCID value. The MACTAR
global score at 6-month follow-up, when considering the 3
priorities selected at baseline, was lower than that obtained when
considering shifts in priorities. Taking into account shifts in
priorities to calculate the MACTAR global score leads to
decreased sensitivity to change (SRM and MCID values) for
patients who considered their condition as improved and increased
sensitivity to change for those who considered their condition
deteriorated. This finding is not surprising because defining a new
priority at follow-up means that one activity or task had become
more difficult to realize than the one chosen at baseline and
omitted at follow-up. This observation raises the question of how
the MACTAR should be used in clinical research and practice.
Changes in MACTAR score considering priorities defined at
baseline at 6-month evaluation reflect the evolution of patients’
perceived handicap in 3 specific activities defined as a priority at
baseline but that may have become less important to the patient at
follow-up. Changes in MACTAR score considering shifts in
priorities at 6 months reflect the evolution of patients’ perceived
global priority handicap; it reflects a more pragmatic approach to
capturing how a ‘‘global priority burden’’ has changed over time.
These 2 ways of measuring changes in MACTAR global score
over time are probably complementary. Taking into account shifts
in priorities in calculating the MACTAR global score would
probably lead to the instrument’s lack of sensitivity to change in
clinical trials. Moreover, it can be argued that the aim at baseline
is to reduce limitations in participation in activities defined as a
priority at this time, and therefore, priorities at baseline should be
considered for calculating the MACTAR global score at follow-up.
Furthermore, the validity of comparing 2 sets of global scores
calculated from different items at baseline and follow-up and
calculating change scores from them should be further analyzed.
However, the MACTAR scale, whether baseline priorities are
retained or shifted, discriminates well between patients who
considered their condition improved and those deteriorated, and
changes in MACTAR score considering shifts in priorities were
associated with patients’ opinion of their health status at follow-up
evaluation on multivariate analysis, which suggests the validity of
considering shifts in priorities. Finally, for epidemiological surveys
aimed at describing clinical situations and their evolution, taking
into account shifts in priorities may add useful qualitative
information about limitations in participation over time.
Table 4. Changes in MACTAR scores for patients with chronic low back pain who considered that their condition had improved,
had not changed, and had deteriorated at 6-month follow-up.
Patients whose condition improved
Patients whose condition had not
changed Patients whose condition deteriorated
(N=46) (N=18) (N=36)
Mean S.D. Min Max SRM ES Mean S.D. Min Max SRM ES Mean S.D. Min Max SRM ES P value
MACTAR *(0–30) 5.29 8.07 212.2 21.8 0.66 1.0 0.53 6.09 214.7 13.7 0.02 0.09 21.45 6.93 218.6 22.0 20.21 20.26 0.0000
MACTAR**(0–30) 3.18 8.29 216.2 21.8 0.38 0.60 0.05 6.13 214.7 13.7 0.008 0.009 23.16 6.77 218.6 22.0 20.46 20.58 0.001
MACTAR: McMaster-Toronto Arthritis Patient Preference Disability Questionnaire
P value: comparison between patient opinion status acceptable vs. not acceptable. Comparisons were performed by Mann Whitney test. This test was performed after
recoding the actual status of health in two groups: condition considered improved or deteriorated (identical and worse).
*considering priorities defined at baseline at 6-month evaluation;
**considering shifts in priorities at 6-month evaluation.
doi:10.1371/journal.pone.0020274.t004
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patients who shifted priorities from baseline did not differ from
those of patients who retained their baseline priorities. The only
differences were changes in scores for the FABQ Work and the
MACTAR score when considering a shift in priorities. Patients
who shifted priorities had higher FABQ Work scores at follow-up.
This finding is not surprising because work activities were fifth in
priority at baseline and became first in priority at follow-up, so for
these patients, work activities became a priority over time. As
expected, these patients had higher MACTAR scores at follow-up
because selecting a new priority activity meant that they were
more handicapped by this new priority than the one chosen at
baseline and omitted at follow-up.
As was previously reported in a cross-sectional analysis of
baseline data [21], we found only moderate correlation between
changes in the MACTAR score and changes in the QUEBEC
score at follow-up, which suggests that both instruments are not
redundant and that disability priorities do not totally reflect global
disability assessed with pre-determined items. The weak correla-
tion between change in the MACTAR score and change in the
VAS for LBP or sciatic pain suggests that patients are able to
differentiate between handicap and pain.
Although the MACTAR approach could closely reflect real-life
limitations in participation and may be of help for clinical decisions,
it has potential limitations for use as a qualitative as well as a
quantitative outcome measure. Use of the MACTAR might not be
an easy, cost-effective instrument. This point should be assessed in
further studies. Moreover, whether the instrument measures
change rather than just unrealistic desires is unclear. This latter
limitation also applies to outcome measures with predefined items
assessing limitations in participation that are widely used in clinical
situations such as LBP. However, the strength of the MACTAR is
that the concept of measuring priorities in disabilities may apply to
all clinical situations inducing disability.
In conclusion, the MACTAR is an outcome measure that is
sensitive to change. Recording patients’ shifts in priority of
activities that cause them trouble can provide a qualitative analysis
of limitations in participation that probably gives accurate
information on what matters most to patients. However, clinical
investigators must be aware that taking into account shifts in
priority activities to calculate the MACTAR global score probably
leads to the instrument’s lack of sensitivity to change when
measuring improvement.
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